Table VIII.
Variable | Low-dose group (n=44) | Middle-dose group (n=42) | High-dose group (n=39) | F value | P-value |
---|---|---|---|---|---|
IL-6 (pg/ml) | |||||
Before treatment | 482.4±36.5 | 483.8±37.2 | 486.7±38.8 | 0.140 | 0.870 |
After treatment | 308.7±28.3 | 226.3±21.8b | 118.7±21.7a,b | 635.062 | <0.001 |
t value | 26.807 | 41.076 | 55.450 | ||
P-value | <0.001 | <0.001 | <0.001 | ||
IL-10 (µg/ml) | |||||
Before treatment | 124.6±11.8 | 126.5±10.9 | 123.4±14.5 | 0.644 | 0.527 |
After treatment | 142.5±21.2 | 168.9±20.8b | 211.6±24.5a,b | 101.621 | <0.001 |
t value | 4.262 | 9.987 | 17.961 | ||
P-value | <0.001 | <0.001 | <0.001 |
P<0.05 compared with the middle-dose group
P<0.05 compared with low-dose group.